Comparing Real-World Effectiveness of Dulaglutide and Insulin as the First Injectable for Patients with Type 2 Diabetes: An Australian Single-Site Retrospective Chart Review

AIM: To compare the real-world effectiveness of once-weekly dulaglutide 1.5 mg with insulin in injectable-naïve patients with type 2 diabetes mellitus (T2DM). METHODS: A non-interventional, non-randomised, observational, single-site retrospective chart review enrolled 150 patients, 75 receiving dula...

Descripción completa

Detalles Bibliográficos
Autores principales: Houssarini, Jared A., Brnabic, Alan J. M., Obaid, Marwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776933/
https://www.ncbi.nlm.nih.gov/pubmed/34850355
http://dx.doi.org/10.1007/s13300-021-01184-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776933/
https://www.ncbi.nlm.nih.gov/pubmed/34850355
http://dx.doi.org/10.1007/s13300-021-01184-x

Ejemplares similares